EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 23-Oct-2026 22:16 ET (24-Oct-2026 02:16 GMT/UTC)

5-Aug-2026

New insights into MYH9 reveal expanding role in cancer and genetic disorders

Compuscript Ltd
Peer-Reviewed Publication

A comprehensive new review article highlights the growing importance of the MYH9 gene as a central player in both cancer biology and inherited genetic conditions, offering fresh perspectives on its potential as a therapeutic target.

Journal: Genes & Diseases

5-Aug-2026

Hidden microbial ecosystems inside tumors reveal new frontiers for cancer treatment

Compuscript Ltd
Peer-Reviewed Publication

A growing body of evidence is reshaping how cancer is understood, placing the spotlight on intra-tumoral microbiota as powerful yet previously overlooked players within the tumor microenvironment. Far from being sterile, tumors host complex communities of bacteria, fungi, and viruses that actively influence disease progression, immune responses, and treatment outcomes.

Journal: Genes & Diseases

5-Aug-2026

New insights into FOXK2 reveal expanding role in cancer biology and clinical care

Compuscript Ltd
Peer-Reviewed Publication

A comprehensive new review highlights the growing importance of FOXK2, a versatile transcription factor, in shaping cancer behavior and influencing clinical outcomes across a wide range of tumor types. The article brings together emerging knowledge to clarify how this gene functions in cancer and why it is attracting increasing attention as a potential diagnostic and prognostic marker.

Journal: Genes & Diseases

5-Aug-2026

Scientists unveil more than 600 new tissue models of human cancer

Massachusetts Institute of Technology
Peer-Reviewed Publication

An international team developed nearly 700 new cancer models, derived from patient tumors, which they hope will aid in drug development. The cells represent 25 different types of cancer and are available for researchers around the world to use.

Journal: Nature
Funder: Wellcome Trust

5-Aug-2026

CS18: a new drug that can potentially overcome cancer drug resistance

Baylor College of Medicine
Peer-Reviewed Publication

Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings support exploring the possibility of using CS18 to treat human cancer in the future.

Journal: Science Advances

5-Aug-2026

First-in-class small molecule inhibitor designed with AI support shows promise against pancreatic cancer in preclinical studies

Mayo Clinic
Peer-Reviewed Publication

Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1 protein that helps different types of cancer, including pancreatic cancer, to grow and resist treatment.

Journal: Cell Reports
Funder: National Institutes of Health, Florida State Fund for the Casey DeSantis Cancer Research Program, U.S. Department of Defense

5-Aug-2026

Collaborative team doubles number of in vitro patient-derived cancer models available for research

Dana-Farber Cancer Institute
Peer-Reviewed Publication

Investigators from Dana-Farber, the National Institutes of Health, The Broad Institute, the Wellcome Sanger Institute and more joined forces to create a public resource of patient-derived cancer models with related clinical and molecular data to advance precision oncology research.

Journal: Nature

5-Aug-2026

MSK scientists find the 'molecular switch' that heals the gut — and that colorectal cancer hijacks to spread

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

MSK researchers identified a protein called ZFP36L2 that acts as a critical "molecular switch" controlling how gut cells repair themselves after injury — a mechanism that colorectal cancer hijacks to spread to other organs. The findings could point toward new treatments that exploit cancer cells' dependence on this protein to stop metastasis or overcome treatment resistance.

Journal: Nature
Funder: Howard Hughes Medical Institute

5-Aug-2026

UCLA researchers receive NIH grant to boost the effectiveness of cancer immunotherapy

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Dr. Cristina Puig-Saus, an associate professor of microbiology, immunology and molecular genetics and surgical oncology at the David Geffen School of Medicine at UCLA and an investigator at the UCLA Health Jonsson Comprehensive Cancer Center, and her research team have received a five-year, $3.9 million grant from the National Cancer Institute to develop drug-based strategies that could enhance cancer immunotherapy for patients with melanoma and potentially other types of cancer.

5-Aug-2026

Cancer Dependency Map now includes next-generation 3D cancer models

Broad Institute of MIT and Harvard
Peer-Reviewed Publication

DepMap scientists have generated dependency data on nearly 150 three-dimensional cancer cell models across 10 cancer types.

The updated catalog reveals cancer phenotypes, cell states, and gene dependencies that are missed in traditional cell lines and shows that both model types are complementary because each captures biology that the other misses.

The integration of data on 2D and 3D models creates a more comprehensive DepMap, moving the resource towards its goal of capturing the complete landscape of cancer vulnerabilities.

Journal: Nature
Funder: Robertson Foundation, 3000 Miles to the Cure Foundation